92 related articles for article (PubMed ID: 24263076)
1. A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males.
Janić M; Lunder M; Prezelj M; Šabovič M
J Cardiopulm Rehabil Prev; 2014; 34(3):208-12. PubMed ID: 24263076
[TBL] [Abstract][Full Text] [Related]
2. The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial.
Lunder M; Janić M; Jug B; Sabovič M
Eur J Intern Med; 2012 Apr; 23(3):261-6. PubMed ID: 22385885
[TBL] [Abstract][Full Text] [Related]
3. Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus.
Lunder M; Janić M; Savić V; Janež A; Kanc K; Šabovič M
Diabetes Res Clin Pract; 2017 May; 127():181-186. PubMed ID: 28384560
[TBL] [Abstract][Full Text] [Related]
4. Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients.
Savić V; Eržen B; Janić M; Lunder M; Boncelj M; Kanc K; Janež A; Šabović M
Diab Vasc Dis Res; 2013 Sep; 10(5):420-5. PubMed ID: 23811602
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Fluvastatin and Valsartan Rejuvenate the Arterial Wall Through Telomerase Activity Increase in Middle-Aged Men.
Janić M; Lunder M; Cerkovnik P; Prosenc Zmrzljak U; Novaković S; Šabovič M
Rejuvenation Res; 2016 Apr; 19(2):115-9. PubMed ID: 26214555
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
[TBL] [Abstract][Full Text] [Related]
7. Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.
Janić M; Lunder M; France Štiglic A; Jerin A; Skitek M; Černe D; Marc J; Drevenšek G; Šabovič M
Vascul Pharmacol; 2017 Dec; 99():45-52. PubMed ID: 28951255
[TBL] [Abstract][Full Text] [Related]
8. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
9. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis.
Li Z; Iwai M; Wu L; Liu HW; Chen R; Jinno T; Suzuki J; Tsuda M; Gao XY; Okumura M; Cui TX; Horiuchi M
Hypertension; 2004 Nov; 44(5):758-63. PubMed ID: 15452025
[TBL] [Abstract][Full Text] [Related]
10. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.
Fliser D; Buchholz K; Haller H;
Circulation; 2004 Aug; 110(9):1103-7. PubMed ID: 15313950
[TBL] [Abstract][Full Text] [Related]
11. Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan.
Boncelj Svetek M; Eržen B; Kanc K; Šabovič M
J Diabetes Complications; 2017 Mar; 31(3):544-550. PubMed ID: 28012835
[TBL] [Abstract][Full Text] [Related]
12. [Influence of valsartan, fluvastatin extended release and their combination on arterial pressure, parameters of lipid metabolism, and endothelial function in patients with hypertensive disease].
Soboleva GN; Pogorelova OA; Kuznetsova TV; Masenko VP; Fomicheva OA; Chernova NA; Rogoza AN; Balakhonova TV; Karpov IuA
Kardiologiia; 2007; 47(11):9-13. PubMed ID: 18260957
[TBL] [Abstract][Full Text] [Related]
13. Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
Rajagopalan S; Zannad F; Radauceanu A; Glazer R; Jia Y; Prescott MF; Kariisa M; Pitt B
Am J Cardiol; 2007 Jul; 100(2):222-6. PubMed ID: 17631074
[TBL] [Abstract][Full Text] [Related]
14. Reduction of age-associated arterial wall changes by low-dose valsartan.
Lunder M; Janic M; Sabovic M
Eur J Prev Cardiol; 2012 Dec; 19(6):1243-9. PubMed ID: 21933833
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation.
Horiuchi M; Cui TX; Li Z; Li JM; Nakagami H; Iwai M
Circulation; 2003 Jan; 107(1):106-12. PubMed ID: 12515751
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
Imanishi T; Ikejima H; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertens Res; 2008 Jun; 31(6):1199-208. PubMed ID: 18716369
[TBL] [Abstract][Full Text] [Related]
17. Improvement of arterial wall phenotype in subjects at moderate cardiovascular risk induced by very low-dose fluvastatin/valsartan combination: a pilot study.
Turk Veselič M; Žorž N; Eržen B; Škerl P; Novaković S; Janić M; Šabovič M
Int Angiol; 2018 Oct; 37(5):356-364. PubMed ID: 29952159
[TBL] [Abstract][Full Text] [Related]
18. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
Cortellaro M; Cofrancesco E; Boschetti C; Cortellaro F; Mancini M; Mariani M; Paoletti R
Thromb Haemost; 2000 Apr; 83(4):549-53. PubMed ID: 10780315
[TBL] [Abstract][Full Text] [Related]
19. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
20. Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation: studies in hypercholesterolemic and hypertensive patients.
Hussein O; Shneider J; Rosenblat M; Aviram M
J Cardiovasc Pharmacol; 2002 Jul; 40(1):28-34. PubMed ID: 12072574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
